Immunohistochemical Expression of MSH2 and MSH6 Mismatch Repair Proteins and Their Pathological Correlations in Canine Primary Pulmonary Carcinoma. [PDF]
Morar A +6 more
europepmc +1 more source
Is pembrolizumab as safe and efficient as neoadjuvant treatment in localized dMMR/MSI esophagogastric cancers? Results from the IMHOTEP phase II study. [PDF]
Coutzac C +13 more
europepmc +1 more source
Machine Learning-Based Pathomics Signature in Predicting MSH2 Expression and Prognosis in Gastric Cancer. [PDF]
Zhang ZR +7 more
europepmc +1 more source
Is there a role for impaired DNA mismatch repair system in the pathogenesis of ameloblastomas? A scoping review. [PDF]
Martins-de-Barros AV +7 more
europepmc +1 more source
Treating microsatellite unstable metastatic parathyroid carcinoma with anti-PD1 therapy. [PDF]
Amir-Kabirian B +5 more
europepmc +1 more source
Exceptional Response to Pembrolizumab Immunotherapy in a Young Patient With Lynch Syndrome-Associated Metastatic Colorectal Cancer. [PDF]
Niazi M, Crossley R.
europepmc +1 more source
DNA Damage Response Alterations Stratify Response to ICI-Based Therapy in Advanced NSCLC with High PD-L1 Expression. [PDF]
Hao F, Zhang L, Zhong D.
europepmc +1 more source
Striking Discordance Between Morphological Residual Disease and Histological Pathological Complete Response: A Case Report of Pembrolizumab Treatment in Mismatch Repair-Deficient Colorectal Cancer With Liver Metastases. [PDF]
Ito K +4 more
europepmc +1 more source
<i>MSH6</i> gene methylation on clinical pathology and diagnosis in retinoblastoma: a bioinformatics analysis. [PDF]
Zhang CF, Zhao L, Jian TM, Guo YF.
europepmc +1 more source
Sessile serrated lesions of the appendix: a contemporary review of the literature. [PDF]
Csonka B, Lantos T, Sejben A.
europepmc +1 more source

